SEOUL, South Korea, Nov. 4 /PRNewswire-FirstCall/ -- RNL BIO Co., Ltd, (www.rnl.co.kr) a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that it treated an American college student who was suffering from autoimmune hearing loss and she gained her hearing back in two months after treatment.
Ever since Dr. Sohl met Dr. Jeong Chan Ra, CEO of the firm, they began to see hope in Chloe's hearing. Dr. Ra established RNL Life Science in California to promote stem cell banking and to introduce the benefit of stem cell therapy through medical tourism. He held a seminar on April 20, 2009 with 30 doctors from Southern California on the topic of adult stem cell therapy in San Pedro, California. Among the attendees was Dr. Sohl, who was stunned at RNL BIO's achievements in stem cell therapeutics that was able to improve various conditions by stem cell treatment. The principle of adult stem cell therapy is actually simple because it utilizes the natural healing ability of our own body.
Earlier this year, RNL BIO treated patients with atopic dermatitis. Other autoimmune disorders have also been treated in addition to atopy. Many stem cell researchers have demonstrated that mesenchymal stem cells modulate the immune system and suppress inflammation as a major therapeutic effect. Chloe's hearing loss falls into this example. This treatment was supposed to soothe any hypersensitive immune response and repair damaged organ so that she might hear again.
Chloe said, "I felt very good about it. I felt very optimistic. I've had IV's every month since I started to lose my hearing. It was good because I knew this could work unlike the other ones. I just felt very optimistic about the whole procedure."
Chloe visited Dr. Won, a plastic surgeon in Los Angeles to harvest her fat tissue around her belly button in last June. Then the tissue was sent to the laboratory RNL BIO in Germantown, Maryland, where they isolated stem cells, put them in liquid nitrogen shipper and transported them to RNL BIO in Seoul, Korea. It took them a month to expand her stem cells to a sufficient amount enough to treat her hearing loss. Chloe's family planned a trip to Korea during their summer vacation. At last, on July 27, 2009, they visited Korea for two weeks. The stem cell treatment took place in Japan -- 600 million cells were administered by three injections with 5 day intervals. The cells were injected into her veins and auditory system.
Dr. Jotterand could not bear her excitement, "Now it's just been a 180 degree turnaround. She's just enjoying life and enjoying being a freshman at the university. She's just having a great time and it's just wonderful to see the joy in her own face and in her life."
President and CEO of RNL BIO, Dr. Ra stated, "Through this great discovery and research of adult stem cells, I am committed to create and develop therapies that will not only prevent diseases, but ensure a better quality of life for all."
For questions regarding the press conference or receiving stem cell therapy, please contact Jin Han Hong, Ph.D., managing director at email@example.com.
CONTACT: Jin Han Hong, Ph.D., managing director of RNL BIO Co., Ltd,
Web site: http://www.rnl.co.kr/